US Patent Issued to B-Portal Biologics on Sept. 1 for "Fusion constructs and uses thereof" (New York Inventor)

ALEXANDRIA, Va., Sept. 1 -- United States Patent no. 12,723,071, issued on Sept. 1, was assigned to B-Portal Biologics Inc. (New York).

"Fusion constructs and uses thereof" was invented by Daniel Chain (New York).

According to the abstract* released by the U.S. Patent & Trademark Office: "Fusion constructs are described. A fusion construct contains a peptide of SEQ ID NO: 2, SEQ ID NO: 3, SEQ ID NO: 4, SEQ ID NO: 5, or SEQ ID NO: 28, fused to a peptide or protein (e.g., an antibody). As compared to the peptide or protein, fusion constructs exhibits improved penetration through the BBB, and are released on the abluminal surface of the BBB, after the post-luminal surface uptake. Fusion constructs could be used in drug discovery, diagnosis, ...